Cognition Therapeutics Files 8-K

Ticker: CGTX · Form: 8-K · Filed: Mar 12, 2025 · CIK: 1455365

Cognition Therapeutics INC 8-K Filing Summary
FieldDetail
CompanyCognition Therapeutics INC (CGTX)
Form Type8-K
Filed DateMar 12, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 8-K, other-events

Related Tickers: COGT

TL;DR

COGT filed an 8-K, something happened, details TBD.

AI Summary

Cognition Therapeutics, Inc. filed an 8-K on March 12, 2025, reporting other events. The filing does not contain specific details about the nature of these events, dollar amounts, or new dates beyond the filing date itself.

Why It Matters

This filing indicates a material event has occurred for Cognition Therapeutics, Inc., requiring disclosure to investors, though the specifics are not yet detailed.

Risk Assessment

Risk Level: medium — The filing is an 8-K for 'Other Events', which can cover a wide range of material information, but the lack of specific details in this initial report creates uncertainty.

Key Players & Entities

FAQ

What specific event(s) are being reported under 'Other Events' in this 8-K filing?

The provided text of the 8-K filing does not specify the nature of the 'Other Events' being reported.

When was this 8-K filing submitted to the SEC?

The filing was submitted on March 12, 2025.

What is the exact name of the company filing this report?

The exact name of the registrant is Cognition Therapeutics, Inc.

In which state was Cognition Therapeutics, Inc. incorporated?

Cognition Therapeutics, Inc. was incorporated in Delaware.

What is the principal executive office address for Cognition Therapeutics, Inc.?

The principal executive office is located at 2500 Westchester Avenue Purchase, NY 10577.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 12, 2025 regarding COGNITION THERAPEUTICS INC (CGTX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing